BACKGROUND: Although utility-based quality-of-life instruments are often used in economic evaluations and psychometric instruments in treatment evaluations, these are complementary approaches to assessing outcomes. In this study we developed and tested these two forms of quality-of-life instruments, both based on a single, validated, health classification system. OBJECTIVES: To assess the measurement properties (reliability and validity) of two newly developed psychometric and utility-based instruments for assessing outcomes associated with prostate cancer. METHODS: 141 men with cancer of the prostate (CaP), treated with radical prostatectomy, radiation therapy, hormonal therapy, and/or chemotherapy were assessed with both instruments and other standard psychometric and utility-based instruments. RESULTS: Analyses indicate the test instruments are reliable and valid. Full-scale correlations between the instruments and standard instruments indicate validity, as do correlations of key subscales, and an evaluation of linear associations with the UCLA-Prostate Cancer Symptom Scales. CONCLUSION: Evidence from this study supports the reliability and construct validity of the tested instruments. Prostate cancer outcomes can now be assessed by a combination of psychometric and utility-based methods, allowing a ready comparison of derived outcomes.
BACKGROUND: Although utility-based quality-of-life instruments are often used in economic evaluations and psychometric instruments in treatment evaluations, these are complementary approaches to assessing outcomes. In this study we developed and tested these two forms of quality-of-life instruments, both based on a single, validated, health classification system. OBJECTIVES: To assess the measurement properties (reliability and validity) of two newly developed psychometric and utility-based instruments for assessing outcomes associated with prostate cancer. METHODS: 141 men with cancer of the prostate (CaP), treated with radical prostatectomy, radiation therapy, hormonal therapy, and/or chemotherapy were assessed with both instruments and other standard psychometric and utility-based instruments. RESULTS: Analyses indicate the test instruments are reliable and valid. Full-scale correlations between the instruments and standard instruments indicate validity, as do correlations of key subscales, and an evaluation of linear associations with the UCLA-Prostate Cancer Symptom Scales. CONCLUSION: Evidence from this study supports the reliability and construct validity of the tested instruments. Prostate cancer outcomes can now be assessed by a combination of psychometric and utility-based methods, allowing a ready comparison of derived outcomes.
Authors: Daniel Santa Mina; Andrew G Matthew; John Trachtenberg; George Tomlinson; Crissa L Guglietti; Shabbir M H Alibhai; Paul Ritvo Journal: Can Urol Assoc J Date: 2010-06 Impact factor: 1.862
Authors: Andrew G Matthew; Shabbir M H Alibhai; Tal Davidson; Kristen L Currie; Haiyan Jiang; Murray Krahn; Neil E Fleshner; Robin Kalnin; Alyssa S Louis; B Joyce Davison; John Trachtenberg Journal: Qual Life Res Date: 2014-03-09 Impact factor: 4.147
Authors: Mónica Avila; Yolanda Pardo; Manel Castells; Ferran Ferrer; Ana Boladeras; Joan Pera; Pedro J Prada; Benjamin Guix; Belen de Paula; Helena Hernandez; Angels Pont; Jordi Alonso; Olatz Garin; Karen Bremner; Murray Krahn; Montse Ferrer Journal: Qual Life Res Date: 2014-05-01 Impact factor: 4.147
Authors: Daniel Santa Mina; Crissa L Guglietti; Shabbir M H Alibhai; Andrew G Matthew; Robin Kalnin; Nora Ahmad; Uri Lindner; John Trachtenberg Journal: J Cancer Surviv Date: 2013-12-07 Impact factor: 4.442
Authors: Paul Toren; Shabbir M H Alibhai; Andre Matthew; Michael Nesbitt; Robin Kalnin; Neil Fleshner; John Trachtenberg Journal: Can Urol Assoc J Date: 2009-12 Impact factor: 1.862
Authors: Jennifer Ku; Murray Krahn; John Trachtenberg; Michael Nesbitt; Robin Kalnin; Gina Lockwood; Shabbir M H Alibhai Journal: Can Urol Assoc J Date: 2009-12 Impact factor: 1.862
Authors: Stacy Rush; Shabbir M H Alibhai; Lizhen Xu; Wei Xu; Alyssa S Louis; Andrew G Matthew; Michael Nesbitt; Antonio Finelli; Neil E Fleshner; Robert J Hamilton; Girish Kulkarni; Alexandre Zlotta; Michael A S Jewett; John Trachtenberg Journal: Can Urol Assoc J Date: 2015 May-Jun Impact factor: 1.862
Authors: Ronald C Chen; Peter Chang; Richard J Vetter; Himansu Lukka; William A Stokes; Martin G Sanda; Deborah Watkins-Bruner; Bryce B Reeve; Howard M Sandler Journal: J Natl Cancer Inst Date: 2014-07-08 Impact factor: 13.506